marketcaparena

VNDA

Vanda Pharmaceuticals Inc.

Company overview

Market capitalization
$312.59M
Employees
533
Latest publication
2026-09-29
About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's commercial portfolio includes Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia; HETLIOZ to treat non-24-hour sleep-wake disorders and nighttime sleep disturbances; PONVORY to treat relapsing forms of multiple sclerosis; and NEREUSTM for preventing vomiting induced by motion. It also develops Fanapt (iloperidone), a long acting injectable (LAI) formulation for the treatment of schizophrenia and hypertension; BysantiTM (milsaperidone), for the acute treatment of manic or mixed episodes associated with bipolar I disorder, and for the treatment of schizophrenia and major depressive disorder; HETLIOZ (tasimelteon) to treat jet lag disorder, insomnia, pediatric insomnia, delayed sleep phase disorder, and pediatric Non-24; PONVORY (ponesimod) to treat psoriasis and ulcerative colitis; and NEREUSTM (tradipitant) for prevention of vomiting induced by GLP-1 receptor agonists, as well as treatment of gastroparesis and atopic dermatitis. In addition, the company's products include Imsidolimab, an IL-36R antagonist to treat generalized pustular psoriasis; VTR-297, for the treatment of hematologic malignancies and onychomycosis, and several oncology indications; and VQW-765, small molecule alpha-7 nicotinic acetylcholine receptor partial agonist for the treatment of social/performance anxiety and psychiatric disorders. Further, it develops cystic fibrosis transmembrane conductance regulator activators and inhibitors; and antisense oligonucleotide molecules. The company was incorporated in 2002 and is headquartered in Washington, the District of Columbia.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20232023-03-31 · USDQ4 20222022-12-31 · USDQ3 20222022-09-30 · USDQ2 20222022-06-30 · USDQ4 20212021-12-31 · USDQ3 20212021-09-30 · USDQ2 20212021-06-30 · USD
Total Revenue50,529,000USD62,498,000USD64,482,000USD65,318,000USD64,390,000USD68,019,000USD70,095,000USD67,899,000USD
Cost Of Revenue3,560,000USD4,774,000USD6,238,000USD6,320,000USD6,059,000USD6,236,000USD6,797,000USD6,566,000USD
Gross Profit46,969,000USD57,724,000USD58,244,000USD58,998,000USD58,331,000USD61,783,000USD63,298,000USD61,333,000USD
Research Development36,953,000USD19,237,000USD18,454,000USD24,857,000USD21,490,000USD19,331,000USD19,653,000USD20,248,000USD
Selling General Administrative71,838,000USD36,104,000USD30,182,000USD29,854,000USD33,001,000USD26,747,000USD32,456,000USD28,347,000USD
Other Operating Expenses1,987,000USD———————
Total Operating Expenses110,778,000USD55,720,000USD51,615,000USD55,090,000USD54,870,000USD53,147,000USD52,479,000USD48,964,000USD
Operating Income-63,809,000USD2,004,000USD6,629,000USD3,908,000USD3,461,000USD8,636,000USD10,819,000USD12,369,000USD
Total Other Income Expense Net1,425,000USD3,524,000USD2,984,000USD1,553,000USD329,000USD-26,000USD-97,000USD235,000USD
Income Before Tax-62,384,000USD5,528,000USD9,613,000USD5,461,000USD3,790,000USD8,610,000USD10,722,000USD12,604,000USD
Income Tax Expense129,000USD2,276,000USD2,752,000USD2,191,000USD1,216,000USD1,532,000USD2,951,000USD2,951,000USD
Net Income-62,513,000USD3,252,000USD6,861,000USD3,270,000USD2,574,000USD7,078,000USD7,771,000USD9,653,000USD
Interest Expense—3,524,000USD2,984,000USD1,553,000USD329,000USD———
Tax Provision—2,276,000USD2,752,000USD2,191,000USD1,216,000USD1,532,000USD2,951,000USD2,951,000USD
Net Income From Continuing Ops—3,252,000USD6,861,000USD3,270,000USD2,574,000USD7,078,000USD7,771,000USD9,653,000USD
Ebit—5,528,000USD9,613,000USD5,461,000USD3,790,000USD8,610,000USD10,722,000USD12,604,000USD
Ebitda—6,198,000USD10,276,000USD6,139,000USD4,480,000USD9,316,000USD11,430,000USD13,316,000USD
Depreciation And Amortization—670,000USD663,000USD678,000USD690,000USD706,000USD708,000USD712,000USD
Reconciled Depreciation—670,000USD663,000USD678,000USD690,000USD706,000USD708,000USD369,000USD
Net Income Applicable To Common Shares—3,252,000USD6,861,000USD3,270,000USD2,574,000USD7,078,000USD7,771,000USD9,653,000USD
Selling And Marketing Expenses——2,600,000USD——6,700,000USD——
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20132013-12-31 · USDFY 20122012-12-31 · USD
Total Revenue192,640,000USD254,382,000USD268,682,000USD248,168,000USD227,188,000USD193,118,000USD33,879,000USD32,727,000USD
Cost Of Revenue17,574,000USD24,282,000USD25,629,000USD23,364,000USD24,488,000USD20,508,000USD52,352,000USD129,000USD
Gross Profit192,640,000USD230,100,000USD243,053,000USD224,804,000USD202,700,000USD172,610,000USD33,879,000USD32,598,000USD
Research Development76,823,000USD85,770,000USD75,363,000USD55,577,000USD48,649,000USD43,594,000USD28,190,000USD45,446,000USD
Selling General Administrative122,052,000USD133,885,000USD117,347,000USD127,910,000USD126,536,000USD105,751,000USD24,594,000USD13,882,000USD
Selling And Marketing Expenses500,000USD2,600,000USD6,700,000USD12,600,000USD3,200,000USD900,000USD——
Unclassified Operating Expenses7,217,000USD—————1,495,000USD1,495,000USD
Total Operating Expenses206,592,000USD223,771,000USD200,888,000USD197,565,000USD179,890,000USD150,872,000USD54,279,000USD60,823,000USD
Operating Income-13,952,000USD6,329,000USD42,165,000USD27,239,000USD22,810,000USD21,738,000USD-20,400,000USD-28,225,000USD
Income Before Tax6,339,000USD11,300,000USD42,364,000USD31,655,000USD29,028,000USD25,346,000USD-20,255,000USD-27,664,000USD
Income Tax Expense3,830,000USD5,025,000USD9,212,000USD8,318,000USD-86,525,000USD138,000USD0USD0USD
Tax Provision5,843,000USD5,025,000USD9,212,000USD8,318,000USD-86,525,000USD138,000USD——
Net Income2,509,000USD6,275,000USD33,152,000USD23,337,000USD115,553,000USD25,208,000USD-20,255,000USD-27,664,000USD
Net Income From Continuing Ops11,770,000USD6,275,000USD33,152,000USD23,337,000USD115,553,000USD25,246,000USD-20,255,000USD-27,664,000USD
Ebit-13,952,000USD11,300,000USD42,364,000USD31,655,000USD22,810,000USD21,738,000USD-20,768,000USD-28,545,000USD
Ebitda-13,952,000USD14,033,000USD45,205,000USD34,519,000USD25,702,000USD24,694,000USD-19,273,000USD-27,050,000USD
Depreciation And Amortization3,010,000USD2,733,000USD2,841,000USD2,864,000USD2,892,000USD2,956,000USD1,495,000USD1,495,000USD
Reconciled Depreciation2,515,000USD2,733,000USD2,841,000USD2,864,000USD2,892,000USD2,956,000USD——
Total Other Income Expense Net20,291,000USD4,971,000USD199,000USD4,416,000USD6,218,000USD3,608,000USD145,000USD1,514,000USD
Interest Expense—4,971,000USD199,000USD4,416,000USD6,218,000USD0USD0USD0USD
Net Income Applicable To Common Shares—6,275,000USD33,152,000USD23,337,000USD115,553,000USD25,208,000USD-20,255,000USD-27,664,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
Total Assets412,467,000USD433,525,000USD488,948,000USD601,140,000USD624,746,000USD631,936,000USD656,204,000USD645,115,000USD
Cash And Equivalents55,882,000USD———————
Total Current Assets264,484,000USD293,169,000USD347,262,000USD367,496,000USD394,921,000USD407,910,000USD438,890,000USD432,387,000USD
Other Current Assets33,085,000USD32,281,000USD26,985,000USD21,161,000USD22,209,000USD20,476,000USD15,420,000USD11,759,000USD
Total Liabilities192,282,000USD———————
Total Current Liabilities164,026,000USD135,582,000USD145,162,000USD117,870,000USD121,489,000USD103,923,000USD99,981,000USD89,090,000USD
Other Non Current Liabilities10,054,000USD———————
Total Stockholder Equity220,185,000USD280,765,000USD327,186,000USD465,999,000USD486,329,000USD511,417,000USD538,546,000USD541,223,000USD
Total Equity Including Noncontrolling Interest220,185,000USD———————
Net Receivables59,692,000USD56,879,000USD54,578,000USD50,541,000USD44,993,000USD44,603,000USD47,101,000USD42,753,000USD
Inventory1,678,000USD1,699,000USD1,852,000USD2,042,000USD2,169,000USD1,923,000USD1,726,000USD1,614,000USD
Property Plant Equipment Net17,176,000USD14,065,000USD13,514,000USD11,899,000USD12,468,000USD12,475,000USD12,677,000USD8,194,000USD
Accounts Payable69,994,000USD4,472,000USD4,940,000USD3,140,000USD2,181,000USD5,990,000USD3,498,000USD5,809,000USD
Common Stock60,000USD60,000USD59,000USD59,000USD59,000USD59,000USD58,000USD58,000USD
Retained Earnings-505,846,000USD-443,333,000USD-394,766,000USD-253,579,000USD-230,993,000USD-203,786,000USD-174,292,000USD-169,380,000USD
Accumulated Other Comprehensive Income38,000USD212,000USD629,000USD540,000USD396,000USD383,000USD74,000USD702,000USD
Intangible Assets—115,102,000USD117,089,000USD108,841,000USD110,593,000USD112,344,000USD114,096,000USD115,848,000USD
Total Liab—152,760,000USD161,762,000USD135,141,000USD138,417,000USD120,519,000USD117,658,000USD103,892,000USD
Other Current Liab—125,088,000USD134,667,000USD110,042,000USD114,630,000USD93,539,000USD92,213,000USD80,827,000USD
Capital Stock—60,000USD59,000USD59,000USD59,000USD59,000USD58,000USD58,000USD
Cash—54,034,000USD84,851,000USD70,022,000USD80,983,000USD111,796,000USD102,316,000USD100,497,000USD
Cash And Short Term Investments—202,310,000USD263,847,000USD293,752,000USD325,550,000USD340,908,000USD374,643,000USD376,261,000USD
Net Debt—-40,961,000USD-72,229,000USD-59,107,000USD-69,345,000USD-100,051,000USD-89,956,000USD-92,557,000USD
Short Term Debt—6,022,000USD5,555,000USD4,688,000USD4,678,000USD4,394,000USD4,270,000USD2,454,000USD
Short Long Term Debt Total—13,073,000USD12,622,000USD10,915,000USD11,638,000USD11,745,000USD12,360,000USD7,940,000USD
Short Term Investments—148,276,000USD178,996,000USD223,730,000USD244,567,000USD229,112,000USD272,327,000USD275,764,000USD
Property Plant Equipment Gross—14,065,000USD26,130,000USD11,899,000USD12,468,000USD12,475,000USD24,244,000USD8,194,000USD
Common Stock Shares Outstanding—59,459,982shares59,098,957shares58,873,268shares58,993,990shares58,527,775shares58,308,000shares58,262,000shares
Non Current Assets Total—140,356,000USD141,686,000USD233,644,000USD229,825,000USD224,026,000USD217,314,000USD212,728,000USD
Non Current Liabilities Total—17,178,000USD16,600,000USD17,271,000USD16,928,000USD16,596,000USD17,677,000USD14,802,000USD
Non Current Liabilities Other—10,127,000USD9,533,000USD11,044,000USD9,968,000USD9,245,000USD9,587,000USD9,316,000USD
Non Currrent Assets Other—10,823,000USD11,083,000USD9,831,000USD9,621,000USD10,060,000USD9,101,000USD9,323,000USD
Net Working Capital—157,587,000USD202,100,000USD249,626,000USD273,432,000USD303,987,000USD338,909,000USD343,297,000USD
Unclassified Non Current Liabilities—7,051,000USD7,067,000USD6,227,000USD6,960,000USD7,351,000USD8,090,000USD5,486,000USD
Unclassified Equity—723,766,000USD721,205,000USD718,920,000USD716,808,000USD714,702,000USD712,648,000USD709,785,000USD
Unclassified Non Current Assets———103,073,000USD97,143,000USD89,147,000USD81,440,000USD79,363,000USD
Current Deferred Revenue———————49,786,000USD
Unclassified Current Liabilities———————-49,786,000USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Assets488,948,000USD656,204,000USD648,440,000USD634,247,000USD593,792,000USD533,456,000USD483,748,000USD332,130,000USD
Intangible Assets117,089,000USD114,096,000USD121,369,000USD18,565,000USD20,081,000USD21,559,000USD23,037,000USD24,542,000USD
Other Current Assets26,985,000USD15,420,000USD9,170,000USD17,727,000USD11,996,001USD10,089,000USD14,500,000USD11,998,000USD
Total Liab161,762,000USD117,658,000USD103,530,000USD107,049,000USD88,864,000USD80,190,000USD72,803,000USD56,708,000USD
Total Stockholder Equity327,186,000USD538,546,000USD544,910,000USD527,198,000USD504,928,000USD453,266,000USD410,945,000USD275,422,000USD
Other Current Liab134,667,000USD92,213,000USD78,154,000USD76,418,000USD71,183,000USD62,770,000USD51,454,000USD63,064,000USD
Common Stock59,000USD58,000USD58,000USD57,000USD56,000USD55,000USD54,000USD52,000USD
Capital Stock59,000USD58,000USD58,000USD57,000USD56,000USD55,000USD54,000USD52,000USD
Retained Earnings-394,766,000USD-174,292,000USD-155,392,000USD-157,901,000USD-164,176,000USD-197,328,000USD-220,665,000USD-336,218,000USD
Cash84,851,000USD102,316,000USD135,821,000USD135,029,000USD52,071,000USD61,031,000USD45,072,000USD61,005,000USD
Cash And Short Term Investments263,847,000USD374,643,000USD388,264,000USD466,859,000USD432,813,000USD367,740,000USD312,129,000USD257,360,000USD
Total Current Assets347,262,000USD438,890,000USD432,946,000USD519,292,000USD478,301,000USD409,145,000USD354,136,000USD299,132,000USD
Total Current Liabilities145,162,000USD99,981,000USD87,697,000USD91,436,000USD74,419,000USD65,936,000USD59,505,000USD53,015,000USD
Net Debt-72,229,000USD-89,956,000USD-126,417,000USD-123,888,000USD-39,705,000USD-47,417,000USD-30,470,000USD-61,005,000USD
Short Term Debt5,555,000USD4,270,000USD2,398,000USD2,328,000USD2,311,000USD2,117,000USD2,147,000USD—
Short Long Term Debt Total12,622,000USD12,360,000USD9,404,000USD11,141,000USD12,366,000USD13,614,000USD14,602,000USD—
Short Term Investments178,996,000USD272,327,000USD252,443,000USD331,830,000USD380,742,000USD306,709,000USD267,057,000USD196,355,000USD
Net Receivables54,578,000USD47,101,000USD34,155,000USD33,512,000USD32,467,000USD30,036,000USD26,367,000USD28,780,000USD
Inventory1,852,000USD1,726,000USD1,357,000USD1,194,000USD1,024,999USD1,280,000USD1,140,000USD994,000USD
Accounts Payable4,940,000USD3,498,000USD7,145,000USD12,690,000USD925,000USD1,049,000USD5,904,000USD3,640,000USD
Property Plant Equipment Net13,514,000USD12,677,000USD9,140,000USD10,973,000USD12,385,000USD14,595,000USD15,044,000USD4,417,000USD
Property Plant Equipment Gross26,130,000USD24,244,000USD20,321,000USD10,973,000USD12,385,000USD4,136,000USD15,044,000USD4,417,000USD
Accumulated Other Comprehensive Income629,000USD74,000USD-30,000USD-1,193,000USD-175,000USD239,000USD249,000USD1,000USD
Common Stock Shares Outstanding58,930,157shares58,149,000shares57,557,911shares56,983,171shares56,921,836shares55,190,802shares54,847,060shares53,045,257shares
Non Current Assets Total141,686,000USD217,314,000USD215,494,000USD114,955,000USD115,491,000USD124,311,000USD129,611,999USD32,998,000USD
Non Current Liabilities Total16,600,000USD17,677,000USD15,833,000USD15,613,000USD14,445,000USD14,254,000USD13,297,999USD3,693,000USD
Non Current Liabilities Other9,533,000USD9,587,000USD8,827,000USD15,613,000USD14,445,000USD14,254,000USD13,298,000USD3,693,000USD
Non Currrent Assets Other11,083,000USD9,101,000USD9,985,000USD11,378,000USD8,147,000USD6,641,000USD3,272,999USD4,039,000USD
Net Working Capital202,100,000USD338,909,000USD345,249,000USD427,856,000USD403,882,000USD343,209,000USD294,631,000USD246,117,000USD
Unclassified Non Current Liabilities7,067,000USD8,090,000USD7,006,000USD-6,800,000USD-4,390,000USD-2,757,000USD—-3,693,000USD
Unclassified Equity721,205,000USD712,648,000USD700,216,000USD686,178,000USD669,167,000USD650,245,000USD631,253,000USD611,535,000USD
Unclassified Non Current Assets—81,440,000USD75,000,000USD-11,378,000USD-8,147,000USD-6,641,000USD-3,273,000USD-4,039,000USD
Other Liab———6,800,000USD4,390,000USD2,757,000USD843,000USD3,693,000USD
Other Assets———85,417,000USD83,025,000USD88,157,000USD91,531,000USD4,039,000USD
Net Tangible Assets———508,633,000USD484,847,000USD431,707,000USD387,908,000USD250,880,000USD
Current Deferred Revenue—————-5,817,000USD-5,904,000USD—
Unclassified Current Liabilities———————-13,689,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Net Income-48,567,000USD-141,187,000USD-22,586,000USD-27,207,000USD-29,494,000USD-4,912,000USD-5,324,000USD-4,518,000USD
Depreciation3,527,000USD5,863,000USD2,053,000USD-2,787,000USD1,983,000USD1,973,000USD1,967,000USD1,968,000USD
Stock Based Compensation2,563,000USD2,285,000USD2,112,000USD2,106,000USD2,971,000USD2,863,000USD2,999,000USD2,986,000USD
Other Non Cash Items144,000USD-2,590,000USD895,000USD5,286,000USD1,104,000USD-545,000USD-1,494,000USD-1,517,000USD
Change To Account Receivables-2,333,000USD-4,075,000USD-5,569,000USD-353,000USD2,534,000USD-4,431,000USD-830,000USD-5,164,000USD
Change To Inventory294,000USD-1,280,000USD32,000USD-368,000USD-1,850,000USD-107,000USD-214,000USD263,000USD
Change In Working Capital-7,885,000USD3,026,000USD-8,126,000USD15,322,000USD-1,914,000USD718,000USD-9,641,000USD-4,613,000USD
Total Cash From Operating Activities-50,218,000USD-29,417,000USD-31,626,000USD-15,252,000USD-33,147,000USD-1,817,000USD-14,581,000USD-6,928,000USD
Capital Expenditures-221,000USD-102,000USD-161,000USD-299,000USD-436,000USD-214,000USD-161,000USD-108,000USD
Free Cash Flow-50,439,000USD-29,519,000USD-31,787,000USD-15,551,000USD-33,583,000USD-2,031,000USD-14,742,000USD-7,036,000USD
Investments30,455,000USD44,968,000USD21,362,000USD-15,270,000USD43,902,000USD3,993,000USD12,057,000USD-15,262,000USD
Total Cashflows From Investing Activities20,234,000USD44,866,000USD21,362,000USD-15,270,000USD43,902,000USD3,993,000USD12,057,000USD-15,262,000USD
Net Borrowings-776,000USD-640,000USD-517,000USD-425,000USD-409,000USD———
Total Cash From Financing Activities-776,000USD-640,000USD-517,000USD-425,000USD-1,324,000USD-155,000USD—0USD
Change In Cash-30,920,000USD14,932,000USD-10,961,000USD-30,813,000USD9,480,000USD1,819,000USD-2,456,000USD-22,205,000USD
Begin Period Cash Flow84,954,000USD70,491,000USD81,452,000USD112,265,000USD102,785,000USD100,497,000USD103,422,000USD125,627,000USD
End Period Cash Flow54,034,000USD85,320,000USD70,491,000USD81,452,000USD112,265,000USD102,316,000USD100,966,000USD103,422,000USD
Unclassified Investing Cash Flow-10,000,000USD—————4,390,000USD1,632,000USD
Unclassified Operating Cash Flow—103,186,000USD-5,974,000USD-7,972,000USD-7,797,000USD-1,914,000USD-3,088,000USD-1,234,000USD
Other Cashflows From Financing Activities——-517,000USD—-915,000USD—12,057,000USD-15,262,000USD
Other Cashflows From Investing Activities——————-4,229,000USD-1,524,000USD
Unclassified Financing Cash Flow———————15,262,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Net Income-220,474,000USD-18,900,000USD2,509,000USD6,275,000USD33,152,000USD23,337,000USD115,553,000USD25,208,000USD
Depreciation-950,000USD8,132,000USD3,010,000USD2,733,000USD2,841,000USD2,864,000USD2,892,000USD2,956,000USD
Stock Based Compensation9,474,000USD12,432,000USD14,040,000USD16,279,000USD15,374,000USD13,360,000USD13,458,000USD11,666,000USD
Other Non Cash Items12,757,000USD-4,381,000USD-4,725,000USD-507,000USD3,365,000USD1,708,000USD12,144,000USD167,000USD
Change To Account Receivables-7,463,000USD-13,012,000USD-707,000USD-1,089,000USD-2,469,000USD-3,767,000USD2,342,000USD-11,207,000USD
Change To Inventory-3,466,000USD-29,000USD-771,000USD-4,479,000USD-2,233,000USD-2,876,000USD-722,000USD70,000USD
Change In Working Capital8,308,000USD-6,558,000USD-747,000USD6,074,000USD2,737,000USD4,317,000USD3,125,000USD-7,790,000USD
Total Cash From Operating Activities-109,442,000USD-15,757,000USD12,801,000USD31,984,000USD64,214,000USD51,775,000USD45,947,000USD29,986,000USD
Capital Expenditures-998,000USD-490,000USD-383,000USD-679,000USD-552,000USD-1,795,000USD-1,019,000USD-25,368,000USD
Free Cash Flow-110,440,000USD-16,247,000USD12,418,000USD31,305,000USD63,662,000USD49,980,000USD44,928,000USD4,618,000USD
Investments95,858,000USD-17,430,000USD107,155,000USD50,604,000USD-76,144,000USD-39,704,000USD-67,290,000USD-84,292,000USD
Total Cashflows From Investing Activities94,860,000USD-17,430,000USD-12,056,000USD49,925,000USD-76,696,000USD-41,499,000USD-68,309,000USD-109,660,000USD
Net Borrowings-1,991,000USD-155,000USD0USD0USD————
Total Cash From Financing Activities-2,906,000USD-155,000USD605,000USD734,000USD3,550,000USD5,634,000USD6,264,000USD107,126,000USD
Change In Cash-17,362,000USD-33,505,000USD792,000USD82,958,000USD-9,017,000USD16,016,000USD-16,033,000USD27,414,000USD
Begin Period Cash Flow102,785,000USD136,290,000USD135,498,000USD52,071,000USD61,088,000USD45,072,000USD61,105,000USD34,335,000USD
End Period Cash Flow85,320,000USD102,785,000USD136,290,000USD135,029,000USD52,071,000USD61,088,000USD45,072,000USD61,749,000USD
Other Cashflows From Financing Activities-915,000USD-155,000USD-12,056,000USD734,000USD3,550,000USD5,634,000USD6,264,000USD6,256,000USD
Unclassified Operating Cash Flow81,443,000USD-6,482,000USD-1,286,000USD1,130,000USD6,745,000USD6,189,000USD-101,225,000USD-2,221,000USD
Other Cashflows From Investing Activities—-4,229,000USD—50,604,000USD12,000USD229,000USD-67,290,000USD-25,000,000USD
Unclassified Investing Cash Flow—4,719,000USD-118,828,000USD-50,604,000USD——67,290,000USD25,000,000USD
Unclassified Financing Cash Flow——12,661,000USD—-3,550,000USD-5,634,000USD-6,264,000USD-6,256,000USD
Change To Liabilities———11,793,000USD3,040,000USD3,759,000USD3,508,000USD-618,000USD
Sale Purchase Of Stock———734,000USD3,550,000USD5,634,000USD6,264,000USD107,126,000USD
Cash And Cash Equivalents Changes———82,643,000USD-8,932,000USD15,910,000USD-16,098,000USD27,452,000USD
Issuance Of Capital Stock—————0USD0USD100,870,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
Q2 2026Quarterly · 2026-06-30ProductFanapt35,989,000USDDisclosure
Q2 2026Quarterly · 2026-06-30ProductHetlioz5,576,000USDDisclosure
Q2 2026Quarterly · 2026-06-30ProductNEREUS1,029,000USDDisclosure
Q2 2026Quarterly · 2026-06-30ProductPONVORY7,935,000USDDisclosure
Q1 2026Quarterly · 2026-03-31ProductFanapt29,560,000USD0001628280-26-031667
Q1 2026Quarterly · 2026-03-31ProductHetlioz15,947,000USD0001628280-26-031667
Q1 2026Quarterly · 2026-03-31ProductPONVORY6,211,000USD0001628280-26-031667
Q4 2025Quarterly · 2025-12-31ProductFanapt33,218,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31ProductHetlioz16,389,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31ProductPONVORY7,609,000USDLegacy provider
FY 2025Yearly · 2025-12-31ProductFanapt117,302,000USD0001628280-26-007460
FY 2025Yearly · 2025-12-31ProductHetlioz71,431,000USD0001628280-26-007460
FY 2025Yearly · 2025-12-31ProductPONVORY27,372,000USD0001628280-26-007460
Q3 2025Quarterly · 2025-09-30ProductFanapt31,245,000USD0001628280-25-047317
Q3 2025Quarterly · 2025-09-30ProductHetlioz17,978,000USD0001628280-25-047317
Q3 2025Quarterly · 2025-09-30ProductPONVORY7,035,000USD0001628280-25-047317
Q2 2025Quarterly · 2025-06-30ProductFanapt29,294,000USD0001628280-25-036861
Q2 2025Quarterly · 2025-06-30ProductHetlioz16,192,000USD0001628280-25-036861
Q2 2025Quarterly · 2025-06-30ProductPONVORY7,104,000USD0001628280-25-036861
Q1 2025Quarterly · 2025-03-31ProductFanapt23,545,000USD0001628280-26-031667
Q1 2025Quarterly · 2025-03-31ProductHetlioz20,872,000USD0001628280-26-031667
Q1 2025Quarterly · 2025-03-31ProductPONVORY5,624,000USD0001628280-26-031667
Q4 2024Quarterly · 2024-12-31ProductFanapt26,649,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31ProductHetlioz20,044,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31ProductPONVORY6,492,000USDLegacy provider
FY 2024Yearly · 2024-12-31ProductFanapt94,297,000USD0001628280-26-007460
FY 2024Yearly · 2024-12-31ProductHetlioz76,675,000USD0001628280-26-007460
FY 2024Yearly · 2024-12-31ProductPONVORY27,800,000USD0001628280-26-007460
Q3 2024Quarterly · 2024-09-30ProductFanapt23,919,000USD0001628280-25-047317
Q3 2024Quarterly · 2024-09-30ProductHetlioz17,870,000USD0001628280-25-047317
Q3 2024Quarterly · 2024-09-30ProductPONVORY5,862,000USD0001628280-25-047317
FY 2023Yearly · 2023-12-31ProductFanapt90,873,000USD0001628280-26-007460
FY 2023Yearly · 2023-12-31ProductHetlioz100,167,000USD0001628280-26-007460
FY 2023Yearly · 2023-12-31ProductPONVORY1,600,000USD0001628280-26-007460
FY 2022Yearly · 2022-12-31ProductFanapt94,727,000USD0001628280-25-005761
FY 2022Yearly · 2022-12-31ProductHetlioz159,655,000USD0001628280-25-005761
FY 2022Yearly · 2022-12-31ProductPONVORY0USD0001628280-25-005761
FY 2021Yearly · 2021-12-31ProductFanapt95,146,000USD0001628280-24-003785
FY 2021Yearly · 2021-12-31ProductHetlioz173,536,000USD0001628280-24-003785
FY 2021Yearly · 2021-12-31ProductPONVORY0USD0001628280-24-003785
FY 2020Yearly · 2020-12-31ProductFanapt87,482,000USD0001628280-23-002857
FY 2020Yearly · 2020-12-31ProductHetlioz160,686,000USD0001628280-23-002857
FY 2019Yearly · 2019-12-31ProductFanapt84,208,000USD0001628280-22-003629
FY 2019Yearly · 2019-12-31ProductHetlioz142,980,000USD0001628280-22-003629
FY 2018Yearly · 2018-12-31ProductFanapt77,283,000USD0001347178-21-000005
FY 2018Yearly · 2018-12-31ProductHetlioz115,835,000USD0001347178-21-000005

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.